Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 23Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 16Hodgkin Disease 16Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Burkitt Lymphoma 9Multiple Myeloma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell 6Glioblastoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Gliosarcoma 4Glioma 4Recurrence 3Neoplasms, Plasma Cell 3Neoplasms 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2

Interventions

Etoposide 3Cyclophosphamide 3Vincristine 2Rituximab 2Prednisone 2Doxorubicin 2varlilumab 1prednylidene 1liposomal doxorubicin 1etoposide phosphate 1deltacortene 1Vorinostat 1Ultrasonography 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Lenalidomide 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Endoscopy 1Electrocardiography 1Echocardiography 1Disulfides 1Cytarabine 1Carmustine 1CT-P10 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Primary Effusion × Carmustine × Clear all
NCT00345865 2020-07-14

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
473 enrolled 16 charts
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡